A Competitive Takeout Program designed to help organizations escape the high cost and complexity of legacy metadata ...
Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. When HCA Healthcare, one ...
When HCA Healthcare, one of the largest hospital systems in the U.S., recently told employees it would stop covering blockbuster obesity drugs Zepbound and Wegovy next year, it pointed them to an ...
Weight loss journeys are as unique as the individuals who embark on them. We all have different body types, lifestyles, health histories and goals that shape what we need to achieve lasting results.
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
(Reuters) -Eli Lilly said on Friday it plans to roll out an employer-focused obesity care model early next year, aiming to expand access to its blockbuster weight-loss drug through partnerships with ...
LOS ANGELES, Nov. 7, 2025 /PRNewswire/ -- Gundry MD, the science-based wellness brand founded by renowned heart surgeon and best-selling author Dr. Steven Gundry, has officially launched the Total ...
Please provide your email address to receive an email when new articles are posted on . Use of hormonal birth control was linked with less weight loss after 12 months in a behavioral weight loss ...
Healthy weight loss is all about finding the right balance between exercise and eating healthy, and a weight loss program can help you do that as you work to reach your health goals. However, it can ...
Costly GLP-1 drugs such as Ozempic, Wegovy, Mounjaro and Zepbound could be covered under the new plan A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the ...
A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the works, but any such program could run into problems with voluntary participation and concerns about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback